Australia markets open in 5 minutes

Zomedica Corp. (ZOM)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.1293-0.0010 (-0.77%)
At close: 04:00PM EDT
0.1308 +0.00 (+1.16%)
After hours: 07:44PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 127.69M
Enterprise value 39.92M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.07
Price/book (mrq)0.53
Enterprise value/revenue 1.59
Enterprise value/EBITDA -1.36

Trading information

Stock price history

Beta (5Y monthly) 0.98
52-week change 3-37.50%
S&P500 52-week change 321.61%
52-week high 30.2450
52-week low 30.1200
50-day moving average 30.1350
200-day moving average 30.1683

Share statistics

Avg vol (3-month) 34.84M
Avg vol (10-day) 33.32M
Shares outstanding 5979.95M
Implied shares outstanding 6979.95M
Float 8963.34M
% held by insiders 11.59%
% held by institutions 18.89%
Shares short (28 Mar 2024) 463.99M
Short ratio (28 Mar 2024) 411.47
Short % of float (28 Mar 2024) 46.64%
Short % of shares outstanding (28 Mar 2024) 46.53%
Shares short (prior month 29 Feb 2024) 464.63M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -137.10%
Operating margin (ttm)-155.23%

Management effectiveness

Return on assets (ttm)-7.41%
Return on equity (ttm)-13.61%

Income statement

Revenue (ttm)25.19M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)19.20%
Gross profit (ttm)N/A
EBITDA -25.29M
Net income avi to common (ttm)-34.53M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)90.5M
Total cash per share (mrq)0.09
Total debt (mrq)2.73M
Total debt/equity (mrq)1.14%
Current ratio (mrq)11.06
Book value per share (mrq)0.25

Cash flow statement

Operating cash flow (ttm)-15.97M
Levered free cash flow (ttm)-22.81M